ID S1036

Establishes a moratorium prohibiting administration of human gene therapy products for any infectious disease indication in Idaho, including products labeled as immunizations or vaccines

Defines "human gene therapy products" as products mediating effects through transcription/translation of transferred genetic material, including nucleic acids (plasmids, mRNA), genetically modified microorganisms, genome editing nucleases, and ex vivo modified human cells

Exempts human gene therapy products used for treatment of cancer or genetic disorders from the moratorium

Named the "Doug Cameron Act" after an Idaho rancher who reportedly became paralyzed from the waist down following a genetic immunization

Moratorium remains in effect until July 1, 2035, subject to legislative safety data review, with an effective date of July 1, 2025